ASCEND-2: A Single-Arm, Open-Label, Multicenter Phase II Study of Ceritinib in Adult Patients (pts) with ALK-Rearranged (ALK+) Non-Small Cell Lung Cancer (NSCLC) Previously Treated with Chemotherapy and Crizotinib (CRZ)
Invited conference paper presented and published in conference proceedings

香港中文大學研究人員

其它資訊
著者MOK Shu Kam Tony, SPIGEL David, FELIP Enriqueta, DEMARINIS Filippo, AHN Myung Ju, GROEN Harry J M, WAKELEE Heather A, HIDA Toyoaki, CRINO Lucio, NISHIO Makoto, SCAGLIOTTI Giorgio V, BRANLE Fabrice, EMEREMNI Chetachi, QUADRIGLI Massimiliano, ZHANG Jie, SHAW Alice Tsang
會議名稱ASCO 2015 Annual Meeting
會議開始日29.05.2015
會議國家/地區美國
會議論文集題名ASCO 2015 Annual Meeting
出版年份2015
月份5
日期29
出版地United States of America, Chicago
頁次Board #382, abstr 8059
語言英式英語
關鍵詞NSCLC; ALK+

上次更新時間 2018-22-01 於 20:19